modern approaches in management of patient with medication related osteonecrosis of the jaw

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220705001

Enrollment

139

Registered

2022-07-05

Start date

2021-09-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis of the jaws can be caused by radiation, drugs, infection, trauma, and diminished vascularity bisphosphonate-related osteonecrosis, medication-related osteonecrosis, Osteonecrosis

Interventions

incorporate protein-rich plasma for the treatment with the application of low-level laser therapy.,application of local teriparatide locally to the defective area

Health Services Research,Health Services Research

PRP,recombinant human PTH 1-34

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all patients with MRONJ

Exclusion criteria

Exclusion criteria: no exclusion

Design outcomes

Primary

Measure	Time frame
teriparatide therapy 10 months mg / milligrams	—

Secondary

Measure	Time frame
PRP 10 months ml / milliliters	—

Countries

Iraq

Contacts

Public ContactDiyako karim

university of sulaimani

dyako.karim@gmail.com7702252261

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026